BridgeMD
Long Term Effects of Comparative Types of MSC Treatments.
EU CTIS ID: 2024-517011-74-01
What this study is testing
To evaluate the long-term safety of treatment with Cellcolabs produced MSCs.
- Phase III and phase IV (Integrated)
A plain-language read of the study's public EU CTIS listing. The study team confirms the details.
Who can take part
You may be able to join if
- MSC Treatment Group A Having received treatment with Cellcolabs produced MSCs in any setting, within 12 months of inclusion. 2. Willing and able to comply with the study procedures. 3. Able to read and understand the participant information sheet and informed consent form.
- Non-treated Control Group B. Matching demographic and anthropometric criteria based on the existing cohort of MSC treated study participants. 2. Willing and able to comply with the study procedures, including blood sampling. 3. Able to read and understand the participant information sheet and informed consent form.
You likely can't join if
- 1. It is not possible to verify with a reasonable degree of certainty what MSC treatment the participant received prior to joining the study (Group A only). 2. It is not possible to verify with a reasonable degree of certainty that individuals who are volunteering to join the non-treated control group, did not previously receive MSC treatment (Group B only). 3. Group B: Presents with diseases or conditions which are not present in the active treatment group (Group A) and which may impact significantly on the comparability of the groups. 4. Is not suitable for inclusion for any reason as judged by the investigator, i.e., long-term laboratory follow-up procedures not feasible due to old age.
The study team makes the final eligibility decision.
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 65+ years, 18-64 years. The study team makes the final eligibility decision.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from EU CTIS; the study team decides eligibility.